|
EFCAB7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.602200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.041600E-01 |
| Normal-vs-Stage2 |
7.504600E-01 |
| Normal-vs-Stage3 |
1.682950E-01 |
| Normal-vs-Stage4 |
9.015600E-01 |
| Stage1-vs-Stage2 |
7.115200E-01 |
| Stage1-vs-Stage3 |
6.182800E-01 |
| Stage1-vs-Stage4 |
7.042000E-01 |
| Stage2-vs-Stage3 |
5.041400E-01 |
| Stage2-vs-Stage4 |
9.375800E-01 |
| Stage3-vs-Stage4 |
5.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.574200E-01 |
| Normal-vs-AfricanAmerican |
3.852800E-01 |
| Normal-vs-Asian |
1.834600E-01 |
| Caucasian-vs-AfricanAmerican |
8.898000E-01 |
| Caucasian-vs-Asian |
5.733600E-01 |
| AfricanAmerican-vs-Asian |
5.746000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.869900E-02 |
| Normal-vs-Female |
3.336800E-01 |
| Male-vs-Female |
7.101200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.219600E-01 |
| Normal-vs-Extreme_Weight |
1.429390E-01 |
| Normal-vs-Obese |
3.221000E-01 |
| Normal-vs-Extreme_Obese |
4.976800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.187400E-01 |
| Normal_Weight-vs-Obese |
9.817600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.999800E-01 |
| Extreme_Weight-vs-Obese |
6.462000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.317000E-01 |
| Obese-vs-Extreme_Obese |
9.881000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.084200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.020800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.194200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.100580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.480600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.480800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.303800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.037650E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.020600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.839400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.773600E-01 |
| Normal-VS-Type2 PRCC |
3.765700E-02 |
| Normal-VS-KIRP CIMP |
4.948400E-02 |
| Normal-VS-Unclassified PRCC |
8.083000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.397700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.022800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.734600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.192200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.650820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.398600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.552400E-02 |
| Normal-vs-N1 |
7.010200E-01 |
| Normal-vs-N2 |
9.523000E-01 |
| N0-vs-N1 |
1.015170E-01 |
| N0-vs-N2 |
4.471400E-01 |
| N1-vs-N2 |
8.272600E-01 |
|
|
